Cargando…
mGluR2/3 activation of the SIRT1 axis preserves mitochondrial function in diabetic neuropathy
OBJECTIVES: There is a critical need to develop effective treatments for diabetic neuropathy. This study determined if a selective mGluR2/3 receptor agonist prevented or treated experimental diabetic peripheral neuropathy (DPN) through glutamate recycling and improved mitochondrial function. METHODS...
Autores principales: | Chandrasekaran, Krish, Muragundla, Anjaneyulu, Demarest, Tyler G., Choi, Joungil, Sagi, Avinash R., Najimi, Neda, Kumar, Pranith, Singh, Anmol, Ho, Cheng‐Ying, Fiskum, Gary, Koch, Lauren G., Britton, Steven L., Russell, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740254/ https://www.ncbi.nlm.nih.gov/pubmed/29296613 http://dx.doi.org/10.1002/acn3.484 |
Ejemplares similares
-
Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity
por: Choi, Joungil, et al.
Publicado: (2014) -
NAD(+) Precursors Repair Mitochondrial Function in Diabetes and Prevent Experimental Diabetic Neuropathy
por: Chandrasekaran, Krish, et al.
Publicado: (2022) -
mGluR5, CB1 and neuroprotection
por: Carvalho, Toniana G., et al.
Publicado: (2016) -
Group I mGluRs in Therapy and Diagnosis of Parkinson’s Disease: Focus on mGluR5 Subtype
por: Azam, Shofiul, et al.
Publicado: (2022) -
Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less selective agonist
por: McCullock, Tyler W., et al.
Publicado: (2019)